CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome

BACKGROUND: Approximately 5% to 10% of pancreatic ductal adenocarcinoma (PDAC) has a hereditary basis. In most of these defined hereditary cancer syndromes, PDAC is not the predominant cancer type. Traditional criteria for publicly funded genetic testing typically require the presence of a set combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cremin, Carol, Howard, Sarah, Le, Lyly, Karsan, Aly, Schaeffer, David F., Renouf, Daniel, Schrader, Kasmintan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842519/
https://www.ncbi.nlm.nih.gov/pubmed/29541281
http://dx.doi.org/10.1186/s13053-018-0088-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842519/
https://www.ncbi.nlm.nih.gov/pubmed/29541281
http://dx.doi.org/10.1186/s13053-018-0088-y

Ejemplares similares